Kura Oncology, Inc. (KURA)
Recent Filing Index
| Form | Filed | Qtr End | F_Period | 8K: Earnings Release |
|---|---|---|---|---|
| 10-QLatest | Q1-2026 | 8-K (2026-05-12) · 99.1 | ||
| 10-KLatest | FY-2025 | 8-K (2026-03-05) · 99.1 | 8-K (2026-01-12) · 99.1 | ||
| 10-Q | Q3-2025 | 8-K (2025-11-04) · 99.1 | ||
| 10-Q | Q2-2025 | 8-K (2025-08-07) · 99.1 | ||
| 10-Q | Q1-2025 | 8-K (2025-05-01) · 99.1 | ||
| 10-K | FY-2024 | 8-K (2025-02-26) · 99.1 | ||
| 10-Q | Q3-2024 | 8-K (2024-11-07) · 99.1 | ||
| 10-Q | Q2-2024 | 8-K (2024-08-08) · 99.1 | ||
| 10-Q | Q1-2024 | 8-K (2024-05-02) · 99.1 | ||
| 10-K | FY-2023 | 8-K (2024-02-27) · 99.1 | 8-K (2024-01-30) · 99.1 | ||
| 10-Q | Q3-2023 | 8-K (2023-11-02) · 99.1 | ||
| 10-Q | Q2-2023 | 8-K (2023-08-03) · 99.1 |
Filing Summary
| Report Name | Notes | Fiscal Period (Annual) | Fiscal Period (Quarter) |
|---|---|---|
| Document and Entity Information | ||
| Statements | ||
| Balance Sheets | ||
| Balance Sheets (P) | ||
| Statements of Operations and Comprehensive Loss | ||
| Statements of Stockholders' Equity | ||
| Statements of Cash Flows | ||
| Notes | ||
| Balance Sheet Detail | ||
| Commitments and Contingencies | — |
|
| Cybersecurity Risk Management, Strategy and Governance | — |
|
| Description of Business | — |
|
| Employee Benefit Plan | — |
|
| Fair Value Measurements | ||
| Income Taxes | — |
|
| Insider Trading Arrangements | ||
| Insider Trading Policies and Procedures | — |
|
| Investments | ||
| Kyowa Kirin Collaboration and License Agreement | ||
| Leases | — |
|
| License Agreements | — |
|
| Long-term Debt | — |
|
| Organization and Basis of Presentation | — |
|
| Pay Vs Performance Disclosure | ||
| Related Party Transactions | — |
|
| Segment Reporting | ||
| Share-based Compensation | ||
| Stockholders' Equity | ||
| Subsequent Event | ||
| Summary of Significant Accounting Policies | ||